Onsite Buprenorphine Treatment at Syringe Exchange Programs

PHASE2CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

October 11, 2023

Study Completion Date

March 31, 2024

Conditions
Opiate Addiction
Interventions
BEHAVIORAL

Onsite treatment

Participants will see a buprenorphine treatment provider who will assess for clinical criteria for opioid use disorder and write a prescription for buprenorphine treatment, which will be filled in a community pharmacy.

BEHAVIORAL

Enhanced referral

Participants will receive an expedited appointment at a community health center for evaluation for buprenorphine treatment

DRUG

Buprenorphine

all participants will receive buprenorphine

Trial Locations (3)

10033

Washington Heights CORNER Project, New York

10035

New York Harm Reduction Educators, New York

10451

BOOM!Health Harm Reduction Center, The Bronx

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Montefiore Medical Center

OTHER

NCT03150173 - Onsite Buprenorphine Treatment at Syringe Exchange Programs | Biotech Hunter | Biotech Hunter